Apex Biotechnology Corp. (1733.TW) TAI

34.30

+0.05(+0.15%)

Updated at October 20 09:46AM

Currency In TWD

Valuation

Market Cap3.02B
Enterprise Value2.65B
P/E Ratio21.13
PEG Ratio17.01
Price/Sales Ratio1.71
Price/Book Ratio1.91
Enterprise/Revenue1.49
Enterprise/EBITDA11.86

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.08
Operating Margin0.1

Management Effectiveness

Return On Assets0.07
Return On Equity0.09

Income Statement

Revenue1.85B
Revenue/Share20.57
Gross Profit521.34M
EBITDA221.58M
Net Income128M
Diluted EPS1.27

Balance Sheet

Total Cash674.74M
Total Cash/Share6.83
Total Debt148.18M
Total Debt/Equity0.08
Current Ratio3.3
Book Value Per Share18.13

Price History

52-Week Change17.63
52-Week High37.5
52-Week Low26.4
Moving Average 50 Days32.11
Moving Average 200 Days30.91

Statistics

Average Volume550,321
Shares Outstanding99.95M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.2
Trailing Annual Dividend Yield3.46
Payout Ratio0
Last Split Factor23:20
Last Split DateJuly 01, 2009